A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

Clinical trial NCT01121549 · TERMINATED

Trial details

NCT number: NCT01121549
Sponsor: Pfizer
Status: TERMINATED
Study type: OBSERVATIONAL

Invasive Early Breast Cancer

Start date: 2010-02-01
Primary completion: 2012-12-01
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.